• No results found

<journal title> <article type> Title goes here

N/A
N/A
Info
Downloaden
Protected

Academic year: 2021

Share "<journal title> <article type> Title goes here"

Copied!
1
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Download het nu ( 1 pagina )

Hele tekst

(1)

LATEX template for Hindawi journal articles

<journal title>

<article type>

Title goes here

A. Author

1,2

, B. Author

2

and C. Author

3

1Affiliation one 2Affiliation two 3Affiliation three

Correspondence should be addressed to <corresponding author’s name>: <corresponding author’s email>

Emails: A@gmail.com (A. Author), B@gmail.com (B. Author)

Abstract

Abstract text goes here

Abstract text goes here Abstract text goes here Ab-stract text goes here AbAb-stract text goes here AbAb-stract text goes here Abstract text goes here Abstract text goes here Abstract text goes here Abstract text goes here Abstract text goes here Abstract text goes here Abstract text goes here Abstract text goes here Abstract text goes here Ab-stract text goes here

Keywords: Key1; Key2; Key3

Introduction

Normal section goes here ...

Table 1: Caption of the table.

One Two

Three Four

Figure 1: Caption of the figure

References

[1] J. Bruix and M. Sherman, “Management of hepa-tocellular carcinoma: an update”, Hepatology, vol. 53, no. 3, pp. 1020–1022, 2011.

Referenties

Download het nu ( PDF - 1 pagina - 37.70 KB )

GERELATEERDE DOCUMENTEN

Presentation Title

The first main message of your talk in one or two lines. The second main message of your talk in one or

Title: Vulvar squamous cell carcinoma : genetics, morphology and clinical behaviour

Chapter 2 describes the design of a somatic mutations profiling panel using mass spectrometry that is created especially for gynaecological cancers, focussing on

Title: Pharmacogenetics of sunitinib in metastatic renal cell carcinoma

Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with

Title: Pharmacogenetics of sunitinib in metastatic renal cell carcinoma

(a) Empirical Bayes estimates of clearance of sunitinib (CLp) and the active metabolite SU12662 (CLm) for base model stratified by different genotypes of single

Title: Pharmacogenetics of sunitinib in metastatic renal cell carcinoma

Supplementary Table 1 – Overview of single nucleotide polymorphisms and haplotypes in candidate genes related to the pharmacokinetics and pharmacodynamics of sunitinib that were

Title: Pharmacogenetics of sunitinib in metastatic renal cell carcinoma

Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with

Title: Pharmacogenetics of sunitinib in metastatic renal cell carcinoma

Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with

Title: Developing an antisense oligonucleotide treatment for Spinocerebellar Ataxia Type 3

Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects). Mechanistic understanding for the